Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.

Your browser appears to have cookies disabled. For the best experience of this website, please enable cookies in your browser

We'll assume we have your consent to use cookies, for example so you won't need to log in each time you visit our site.
Learn more

Leukaemia patients 'could be cured'

  • 1 Comment

Chronic myeloid leukaemia (CML) patients could be cured of the disease by a standard drug treatment, according to a trial study.

Professor Francois-Xavier Mahon, who led the study published in the Lancet Oncology, discovered that a proportion of patients with CML remained completely free of the disease two years after doctors stopped treating them with imatinib (Glivec).

The drug treatment works by switching off an enzyme linked to the cancer, which in turn reduces levels of an abnormal protein called BCR/ABL.

The results have led experts to believe that at least some patients with CML can be cured by imatinib and appears to quash the notion that the slow-growing form of cancer would always return if treatment is halted.

A study of 69 CML patients was designed to see whether complete molecular remission (CMR) can continue after ending imatinib treatment. It found that CMR was maintained in 41% of patients one year after treatment stopped, and in 38% of patients who had not been prescribed imatinib for up to two years.

  • 1 Comment

Readers' comments (1)

  • Does anyone know please the title and date of this Lancet article as the link ends up with ' article cannot be found. thanks

    Unsuitable or offensive? Report this comment

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.